Skip to main content

Advertisement

SpringerLink
Log in

Can vitamin D slow down the progression of chronic kidney disease?

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Pharmacological blockade of the renin–angiotensin–aldosterone system (RAAS) is the cornerstone of renoprotective therapy, and the reduction of persistent RAAS activation is considered to be an important target in the treatment of chronic kidney disease (CKD). Vitamin D is a steroid hormone that controls a broad range of metabolic and cell regulatory functions. It acts as a transcription factor and can suppress the renin gene, thereby acting as a negative endocrine regulator of RAAS. RAAS activation can reduce renal Klotho expression, and the Klotho–fibroblast growth factor 23 interaction may further reduce the production of active vitamin D. Results from both clinical and experimental studies suggest that vitamin D therapy is associated with a reduction in blood pressure and left ventricular hypertrophy and improves cardiovascular outcomes. In addition, a reduction in angiotensin II through RAAS blockade may have anti-proteinuric and anti-fibrotic effects. Vitamin D has also been shown to modulate the immune system, regulate inflammatory responses, improve insulin sensitivity and reduce high-density lipoprotein cholesterol. Taken together, these pleiotropic effects of vitamin D may slow down the progression of CKD. In this review, we discuss the experimental and early clinical findings that suggest a renoprotective effect of vitamin D, thereby providing an additional rationale beyond mineral metabolism for the close monitoring of, and supplemention with vitamin D from the earliest stages of CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  PubMed  CAS  Google Scholar 

  2. Shroff R, Knott C, Rees L (2010) The virtues of vitamin D—but how much is too much? Pediatr Nephrol 25:1607–1620

    Article  PubMed  Google Scholar 

  3. Zittermann A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94:483–492

    Article  PubMed  CAS  Google Scholar 

  4. Melamed ML, Michos ED, Post W, Astor B (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637

    Article  PubMed  Google Scholar 

  5. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446–456

    Article  PubMed  CAS  Google Scholar 

  6. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858–1865

    Article  PubMed  CAS  Google Scholar 

  7. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004–1013

    Article  PubMed  CAS  Google Scholar 

  8. Fogo AB (2007) Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 22:2011–2022

    Article  PubMed  Google Scholar 

  9. Wingen AM, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 349:1117–1123

    Article  PubMed  CAS  Google Scholar 

  10. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754–762

    PubMed  CAS  Google Scholar 

  11. Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Moller K, Wigger M, Peruzzi L, Mehls O, Schaefer F (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639–1650

    Article  PubMed  Google Scholar 

  12. Volpe M, Savoia C, De PP, Ostrowska B, Tarasi D, Rubattu S (2002) The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J Am Soc Nephrol 13(Suppl 3):S173–S178

    Article  PubMed  CAS  Google Scholar 

  13. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38

    Article  PubMed  CAS  Google Scholar 

  14. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C (2010) Vitamin D: a pleiotropic hormone. Kidney Int 78:140–145

    Article  PubMed  CAS  Google Scholar 

  15. Cardus A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso JM (2006) 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 69:1377–1384

    PubMed  CAS  Google Scholar 

  16. Hsu JJ, Tintut Y, Demer LL (2008) Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol 3:1542–1547

    Article  PubMed  CAS  Google Scholar 

  17. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19:1509–1519

    Article  PubMed  CAS  Google Scholar 

  18. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613–620

    Article  PubMed  CAS  Google Scholar 

  19. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239–1246

    Article  PubMed  CAS  Google Scholar 

  20. Thadhani R, Wolf M (2007) Vitamin D in patients with kidney disease: cautiously optimistic. Adv Chronic Kidney Dis 14:22–26

    Article  PubMed  Google Scholar 

  21. Wolf M, Thadhani R (2005) Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. Semin Dial 18:302–306

    Article  PubMed  Google Scholar 

  22. Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26–34

    Article  PubMed  CAS  Google Scholar 

  23. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229–238

    PubMed  CAS  Google Scholar 

  24. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288:E125–E132

    Article  PubMed  CAS  Google Scholar 

  25. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC (2007) 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282:29821–29830

    Article  PubMed  CAS  Google Scholar 

  26. Tiosano D, Schwartz Y, Braver Y, Hadash A, Gepstein V, Weisman Y, Lorber A (2011) The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res 26:2252–2260

    Article  PubMed  CAS  Google Scholar 

  27. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D (2008) Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1-alpha-hydroxylase knockout mice. Kidney Int 74:170–179

    Article  PubMed  CAS  Google Scholar 

  28. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC (2008) Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 105:15896–15901

    Article  PubMed  CAS  Google Scholar 

  29. Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E (2007) Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol 18:1796–1806

    Article  PubMed  CAS  Google Scholar 

  30. Tan X, Li Y, Liu Y (2006) Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17:3382–3393

    Article  PubMed  CAS  Google Scholar 

  31. Tan X, Wen X, Liu Y (2008) Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 19:1741–1752

    Article  PubMed  CAS  Google Scholar 

  32. Feneis JF, Arora RR (2010) Role of vitamin D in blood pressure homeostasis. Am J Ther 17:e221–e229

    Article  PubMed  Google Scholar 

  33. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511

    Article  PubMed  CAS  Google Scholar 

  34. Rostand SG (2010) Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis. Clin J Am Soc Nephrol 5:1697–1703

    Article  PubMed  CAS  Google Scholar 

  35. Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, Choi EJ, Chang YS, Bang BK (2006) Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract 102:c21–c29

    Article  PubMed  Google Scholar 

  36. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK (1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33:73–81

    Article  PubMed  CAS  Google Scholar 

  37. Mak RH (1992) Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 6:345–348

    Article  PubMed  CAS  Google Scholar 

  38. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea MM, Woo J (2008) Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 87:1631–1638

    PubMed  CAS  Google Scholar 

  39. Shroff R, Knott C, Gullett A, Wells D, Marks S, Rees L (2011) Vitamin D deficiency is associated with short stature and hypertension in paediatric renal transplant recipients. Pediatr Nephrol 26:2227–2233

    Article  PubMed  Google Scholar 

  40. Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, Todd AC, Schwartz BS (2001) Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect 109:383–389

    PubMed  CAS  Google Scholar 

  41. Nakano Y, Oshima T, Sasaki S, Yamaoka K, Matsumoto T, Hirao H, Ozono R, Matsuura H, Kajiyama G, Kambe M (2000) Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration. J Mol Med (Berl) 78:575–579

    Article  CAS  Google Scholar 

  42. Vaidya A, Sun B, Forman JP, Hopkins PN, Brown NJ, Kolatkar NS, Williams GH, Williams JS (2011) The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf) 74:783–790

    Article  CAS  Google Scholar 

  43. Agarwal R (2009) Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol 4:1523–1528

    Article  PubMed  CAS  Google Scholar 

  44. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543–1551

    Article  PubMed  Google Scholar 

  45. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM (2008) Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118:1748–1757

    Article  PubMed  CAS  Google Scholar 

  46. Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996–3003

    Article  PubMed  CAS  Google Scholar 

  47. Shroff RC, Shanahan CM (2007) The vascular biology of calcification. Semin Dial 20:103–109

    Article  PubMed  Google Scholar 

  48. Carthy EP, Yamashita W, Hsu A, Ooi BS (1989) 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13:954–959

    Article  PubMed  CAS  Google Scholar 

  49. Becker LE, Koleganova N, Piecha G, Noronha ID, Zeier M, Geldyyev A, Kokeny G, Ritz E, Gross ML (2010) Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol 300:F772–F782

    Article  PubMed  Google Scholar 

  50. Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA (2006) Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 318:90–98

    Article  PubMed  CAS  Google Scholar 

  51. Baeke F, Gysemans C, Korf H, Mathieu C (2010) Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol 25:1597–1606

    Article  PubMed  Google Scholar 

  52. Zehnder D, Quinkler M, Eardley KS, Bland R, Lepenies J, Hughes SV, Raymond NT, Howie AJ, Cockwell P, Stewart PM, Hewison M (2008) Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 74:1343–1353

    Article  PubMed  CAS  Google Scholar 

  53. Inaguma D, Nagaya H, Hara K, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Kurata K (2008) Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 12:126–131

    Article  PubMed  CAS  Google Scholar 

  54. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115–1125

    Article  PubMed  CAS  Google Scholar 

  55. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773

    Article  PubMed  CAS  Google Scholar 

  56. de Boer I (2008) Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens 17:566–572

    Article  PubMed  Google Scholar 

  57. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, Quigg RJ, Li YC (2008) Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 73:163–171

    Article  PubMed  CAS  Google Scholar 

  58. Praga M, Hernandez E, Morales E, Campos AP, Valero MA, Martinez MA, Leon M (2001) Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 16:1790–1798

    Article  PubMed  CAS  Google Scholar 

  59. Alemzadeh R, Kichler J, Babar G, Calhoun M (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57:183–191

    Article  PubMed  CAS  Google Scholar 

  60. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693

    PubMed  CAS  Google Scholar 

  61. Sneve M, Figenschau Y, Jorde R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159:675–684

    Article  PubMed  CAS  Google Scholar 

  62. Rodriguez-Rodriguez E, Ortega RM, Gonzalez-Rodriguez LG, Lopez-Sobaler AM (2011) Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children. Eur J Nutr 50:373–378

    Article  PubMed  CAS  Google Scholar 

  63. Zittermann A, Gummert JF, Borgermann J (2011) The role of vitamin d in dyslipidemia and cardiovascular disease. Curr Pharm Des 17:933–942

    Article  PubMed  CAS  Google Scholar 

  64. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M, Nangaku M, Hirata Y, Nagai R (2002) In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 39:838–843

    Article  PubMed  CAS  Google Scholar 

  65. Yoon HE, Ghee JY, Piao S, Song JH, Han DH, Kim S, Ohashi N, Kobori H, Kuro-o M, Yang CW (2011) Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant 26:800–813

    Article  PubMed  CAS  Google Scholar 

  66. Shroff R, Shanahan CM (2011) Klotho: an elixir of youth for the vasculature? J Am Soc Nephrol 22:5–7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal Unit, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, WC1N 3JH, UK

    Rukshana Shroff, Mandy Wan & Lesley Rees

Authors
  1. Rukshana Shroff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mandy Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lesley Rees
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rukshana Shroff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shroff, R., Wan, M. & Rees, L. Can vitamin D slow down the progression of chronic kidney disease?. Pediatr Nephrol 27, 2167–2173 (2012). https://doi.org/10.1007/s00467-011-2071-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-011-2071-y

Keywords

Search

Navigation